Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year follow-up (SICOT study)

You will have to log in or register to view the full content. The direct and indirect costs of treating pathology related to discogenic back pain in the United States exceed $100 billion annually [1, 2]. The development of disc degeneration in the lumbar spine is almost universal over the age of 50 years. This observation appears related to humans’ recent evolution to an upright posture and S-shaped spinal column [3–6].

Choose language »